ストックスクリーナーアプリを入手
20.76
3.71%
-0.80
前日終値:
$21.56
開ける：
$21.68
24時間の取引高:
398.56K
Relative Volume:
0.52
時価総額：
$1.29B
収益：
$10.00M
当期純損益:
$-377.74M
株価収益率:
-2.4587
EPS:
-8.4436
ネットキャッシュフロー:
$-172.35M
1週間 パフォーマンス:
+15.27%
1か月 パフォーマンス:
-3.26%
6か月 パフォーマンス:
-32.00%
1年 パフォーマンス:
+84.70%
1日の値動き範囲:
$20.27
$22.15
1週間の範囲:
$17.39
$22.15
52週間の値動き範囲:
$8.51
$44.60
Zenas Biopharma Inc Stock (ZBIO) Company Profile
名前
Zenas Biopharma Inc
セクター
電話
857-271-2954
住所
852 WINTER STREET, SUITE 250, WALTHAM
Compare ZBIO vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZBIO
Zenas Biopharma Inc
|
20.76 | 1.34B | 10.00M | -377.74M | -172.35M | -8.4436 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-20 | 開始されました | Wedbush | Outperform |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2024-12-16 | 開始されました | H.C. Wainwright | Buy |
| 2024-11-05 | 開始されました | Rodman & Renshaw | Buy |
| 2024-10-08 | 開始されました | Citigroup | Buy |
| 2024-10-08 | 開始されました | Guggenheim | Buy |
| 2024-10-08 | 開始されました | Jefferies | Buy |
| 2024-10-08 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Zenas Biopharma Inc (ZBIO) 最新ニュース
Zenas BioPharma (ZBIO) CEO and entities report 3,220,880 shares owned - Stock Titan
Zenas BioPharma rises as CEO continues insider purchases - MSN
A Look At Zenas BioPharma (ZBIO) Valuation After Obexelimab Trial Success And US$300 Million Fundraising - Sahm
ZBIO Stock Price, Quote & Chart | ZENAS BIOPHARMA INC (NASDAQ:ZBIO) - ChartMill
Zenas BioPharma (ZBIO) Price Target Increased by 21.59% to 40.22 - MSN
Zenas: 'Strong Buy' On Obexelimab Enhancement And Expected SLE Data Q4 2026 (NASDAQ:ZBIO) - Seeking Alpha
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity - MarketBeat
Zenas BioPharma rises on CEO insider purchase (ZBIO:NASDAQ) - Seeking Alpha
Zenas BioPharma CEO Makes Bold Move With Major Personal Stock Buy - TipRanks
Zenas BioPharma CEO Moulder buys $1.07m in ZBIO shares By Investing.com - Investing.com Canada
Leon Moulder Jr Purchases 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock - MarketBeat
Zenas BioPharma CEO Moulder buys $1.07m in ZBIO shares - Investing.com UK
Zenas BioPharma (ZBIO) CEO-linked entities purchase 60,000 shares in open market - Stock Titan
Zenas BioPharma announces concurrent public offerings of convertible senior notes and common stock - MSN
Here’s Why Zenas BioPharma (ZBIO) Traded Lower in Q1 - Insider Monkey
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Given Average Rating of "Hold" by Analysts - MarketBeat
Is Zenas BioPharma (ZBIO) stock priced efficiently (Weakens) 2026-04-20Community Pattern Alerts - Cổng thông tin điện tử tỉnh Lào Cai
Zenas Biopharma announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Zenas Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Zenas BioPharma, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 93% Potential Upside Amidst Analyst Enthusiasm - DirectorsTalk Interviews
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Short Interest Up 21.4% in March - MarketBeat
Zenas BioPharma (ZBIO) Stock Volume Deceleration (On the Radar) 2026-04-15Crowd Entry Signals - Cổng thông tin điện tử Tỉnh Sơn La
Zenas BioPharma (NASDAQ:ZBIO) Issues Quarterly Earnings Results - MarketBeat
ZBIO Options Volatility — NASDAQ:ZBIO - TradingView
ZBIO Options Chain — NASDAQ:ZBIO - TradingView
Breakout Zone: Will Zenas BioPharma Inc outperform during market ralliesWeekly Investment Recap & Consistent Growth Stock Picks - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Zenas BioPharma, Inc. (ZBIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Big Picture: Is Zenas BioPharma Inc attractive at current valuationTake Profit & Safe Capital Growth Stock Tips - baoquankhu1.vn
Returns Recap: Can Zenas BioPharma Inc be the next market leader2026 Macro Impact & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Trend Review: What is the target price for Zenas BioPharma Inc stock2026 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
Investor Mood: What are Zenas BioPharma Incs growth levers2026 EndofYear Setup & Expert Approved Trade Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Zenas BioPharma, Inc. (ZBIO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Experienced Healthcare Investor Buys Shares Of Zenas Biopharma – Insider Weekends (NASDAQ:ZBIO) - Seeking Alpha
ZBIO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Assessing Zenas BioPharma (ZBIO) Valuation After US$300 Million Equity And Convertible Notes Financing - Sahm
Zenas BioPharma's Key Milestones and Market Context: Holding Through the BLA (NASDAQ:ZBIO) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Connect - ACCESS Newswire
Zenas BioPharma Director Makes Bold New Move With Fresh Stock Purchase - TipRanks
Zenas BioPharma Director Increases Stake with $70K Stock Purchase - National Today
Lu Hongbo buys Zenas Biopharma (ZBIO) shares worth $70,197 By Investing.com - Investing.com Canada
Lu Hongbo buys Zenas Biopharma (ZBIO) shares worth $70,197 - Investing.com
Insider Buying: Zenas BioPharma (NASDAQ:ZBIO) Director Buys 3,768 Shares of Stock - marketbeat.com
Leon Moulder boosts Zenas BioPharma (ZBIO) stake to 4.794% ownership - Stock Titan
Zenas BioPharma (ZBIO) director-affiliated funds purchase 3,768 shares - Stock Titan
Zenas BioPharma (NASDAQ:ZBIO) Trading Up 7.6% Following Insider Buying Activity - MarketBeat
Zenas Biopharma Inc (ZBIO) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):